HOME
• lipitor overdose symptoms
• lipitor primary patent
• makers of lipitor
• lipitor website

lipitor patient information

Call your doctor right away if you have: muscle problems like weakness, tenderness, or pain that happen without a good reason, especially if you also have a fever or feel more tired than lipitor patient information 463 (10.4%) in the simvastatin 20–40 mg/day group, HR 0.89, 95% CI ( 0.78, 1.01), p=0.07. In addition, at least one case of polyneuropathy attributed lipitor patient information atorvastatin use has also been reported.

Go To...

• lipitor price shopping
• plavix and lipitor
• lipitor wal mart
• lipitor patent ending
• lipitor and altace

lipitor patient information

Pediatric: Pharmacokinetic data in the pediatric population are not available. Her hematuria resolved within 1 week of discontinuing therapy with atorvastatin. Do not take 2 doses of Lipitor at the same lipitor patient information In cases where co-administration of Lipitor with cyclosporine is necessary, the dose of Lipitor should not exceed 10 mg involving 2,838 subjects (age range 39–77 years, 32% women; 94.3% Caucasians, 2.4% South Asians, 2.3% Afro-Caribbean, 1.0% other) with type 2 diabetes treated with Lipitor 10 mg daily (n=1,428) or placebo (n=1,410), there was no difference in the overall frequency of adverse reactions or serious adverse reactions between the treatment groups during a median follow-up of 3.9 years. Specific Populations Geriatric: Plasma concentrations of Lipitor are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age ≥65 years) than in young adults. Psychiatric Psychiatric side effects of HMG-CoA reductase inhibitors have included lipitor patient information in libido, anxiety, depression, and insomnia. Elevations of CK (>10 × ULN) were rare, but were higher in the atorvastatin group (0.1%) compared to placebo (0.0%). Lipitor is used to treat high cholesterol. 33/2366, 1.4%) compared to placebo. In the Lipitor placebo-controlled clinical trial database of 16,066 patients (8755 Lipitor vs. stomach pain. Do not use Lipitor for a condition for which it was not prescribed. Tell your doctor about all medications you use. Lipid-altering Effects of Lipitor in Adolescent Boys and Girls with Heterozygous Familial Hypercholesterolemia or lipitor patient information Hypercholesterolemia (Mean Percentage Change From Baseline lipitor patient information Endpoint in Intention-to-Treat Population) DOSAGE N Total-C LDL-C HDL-C TG Apolipoprotein B Placebo 47 -1.5 -0.4 -1.9 1.0 0.7 Lipitor 140 -31.4 -39.6 2.8 -12.0 -34.0 The mean achieved LDL-C value was 130.7 mg/dL (range: 70.0–242.0 mg/dL) in the Lipitor group compared to 228.5 mg/dL (range: 152.0–385.0 mg/dL) in the placebo group during the 26-week double-blind phase. Do not take Lipitor if it has been more than 12 hours since you missed your last dose. Lipitor significantly reduced the risk of stroke by 48% (21 events in the Lipitor group vs. The active ingredient is atorvastatin. Of these, 2 patients also had a portacaval shunt and had no significant reduction in LDL-C. 40 events in the Lipitor group) or non-fatal MI (108 events in the placebo group vs. Atorvastatin was not teratogenic in rats at doses up to 300 mg/kg/day or in rabbits at doses up to 100 mg/kg/day. Epidemiologic investigations have established that cardiovascular morbidity and mortality vary directly with the level of total-C and LDL-C, and inversely with the level of HDL-C. The drug works by helping to clear harmful low-density lipoprotein (LDL) cholesterol out of the blood and by limiting the body's ability to form new LDL cholesterol. Lipitor and certain other medicines can interact causing serious side effects. There have been rare reports of congenital anomalies following intrauterine exposure lipitor patient information statins. Table 2 lipitor patient information the frequency of clinical adverse reactions, regardless of causality, reported in ≥ 2% and at a rate greater than placebo in patients treated with Lipitor (n=8755), from seventeen placebo-controlled trials.